Wei-Heng Xu (Weiheng Xu)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Epithelial Mesenchymal Transition

Cell Cycle Arrest

Transforming Growth Factor

Top Venues

Journal of medicinal chemistry

Phytotherapy research : PTR

This page only lists publications with an associated author ORCID identifier.

Publications

Guoqing Li, Juanni Lu, Chuanhao Wang, Xuliang Chang, Zhuo Qu, Wannian Zhang, Chun-Lin Zhuang, Zhenyuan Miao, Wei-Heng Xu
Discovery of Sophoridine α-Aryl Propionamide Derivative ZM600 as a Novel Antihepatic Fibrosis Agent. Journal of medicinal chemistry 67 (13) (2024)
Guoqing Li, Juanni Lu, Chuanhao Wang, Xuliang Chang, Zhuo Qu, Wannian Zhang, Chun-Lin Zhuang, Zhenyuan Miao, Wei-Heng Xu
Discovery of Sophoridine α-Aryl Propionamide Derivative ZM600 as a Novel Antihepatic Fibrosis Agent. Journal of medicinal chemistry 67 (13) (2024)
Guoqing Li, Juanni Lu, Chuanhao Wang, Xuliang Chang, Zhuo Qu, Wannian Zhang, Chun-Lin Zhuang, Zhenyuan Miao, Wei-Heng Xu
Discovery of Sophoridine α-Aryl Propionamide Derivative ZM600 as a Novel Antihepatic Fibrosis Agent. Journal of medicinal chemistry (2024)
Lin-Lin Chen, Liu-Yuan Xia, Jun-Ping Zhang, Yan Wang, Jian-Yu Chen, Cheng Guo, Wei-Heng Xu
Saikosaponin D alleviates cancer cachexia by directly inhibiting STAT3. Phytotherapy research : PTR (2022)